Investor Education Series
The KC BioHub Investor Education Series is an initiative developed by KC BioHub to support individuals interested in learning more about early-stage investment in life sciences, biotechnology, and related fields.
Designed for accredited angel investors, the program offers a guided introduction to the biotech ecosystem, covering scientific concepts, regulatory processes, due diligence practices, and market trends. Sessions are supported by experienced practitioners, researchers, and investors with direct knowledge of the field.
Whether you’re looking to expand your portfolio or deepen your understanding of emerging technologies in healthcare, agriculture, and bioengineering, this series offers an accessible way to get started.
What the Program Offers
- A foundational overview of biotech, life sciences, and agtech investing
- Live instruction from subject matter experts with real-world experience
- Opportunities for discussion and Q&A in each session
- Optional access to pitch events, lab tours, and networking with regional companies
- A growing peer community interested in science-backed innovation and regional economic growth
Who Should Participate?
This program is intended for accredited angel investors.
Participants do not need prior biotech experience, just curiosity, openness to learning, and an interest in engaging with Kansas City’s growing life sciences ecosystem. The program is open to investors based locally or internationally.
Fall 2026 Curriculum
Oct 13, 2026 – Life Sciences Investing 101 + Market Opportunity
Set the foundation for new and returning investors. Cover why life sciences investing matters, how it differs from traditional tech investing, what makes the Kansas City opportunity unique, and what investors need to understand before evaluating companies in this space. Case study component as feasible.
Oct 27, 2026 – Deal Sourcing, Pipeline Prioritization + Initial Diligence Screening
Focus on how investors identify opportunities, prioritize pipeline, and conduct early diligence screening. This would include discussion around technical risk, regulatory pathways, IP, clinical/commercial milestones, founder credibility, and scientific validation. This would also be a good session to prepare investors in asking stronger diligence questions. Will have list of suggested questions and DD tools to distribute.
Nov 10, 2026 – Case Study / Active Opportunity Deep Dive
Use this session to go deeper into a case study or active opportunity as a learning example. Discuss detailed diligence, deal terms, investor questions, risk assessment, and what additional information would be needed before moving forward.
Nov 17, 2026 – Case Study / Syndication + Activation Pathways
Use the final session to continue bringing the learning into practice through another case study or active opportunity. Discuss detailed diligence, deal terms, syndication with other investors, and clear next steps for people who want to stay engaged through the first-Tuesday club, diligence groups, BioHub activity, or future investment opportunities.
